Skip to content

Clinical trials

Phase 2/3 Neoplasm Metastasis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2/3 Country / region: France Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20071
20121
20151
20211
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federation Francophone de Cancerologie Digestive2
Sanofi2
Bellus Health Inc. - a GSK company1
BioNTech SE1
Bristol-Myers Squibb1
Eikon Therapeutics1
Exelixis1
Novartis Pharmaceuticals1
Pfizer1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis12
Head and Neck Neoplasms2
Adenoma, Islet Cell1
Amyloidosis1
Anorexia1
Arthritis, Rheumatoid1
Breast Neoplasms1
Cachexia1
Carcinoma, Hepatocellular1
Carcinoma, Transitional Cell1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.